Search research articles
Contact Us
Filters
Showing results (51-60 of 90) with videos related to
Page
of 9
Sort By:
Journal of Human Genetics
|
August 3, 2023
Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development
Haobo Li, Zhu Zhang, Yuting Qiu, et al.
British Journal of Pharmacology
|
February 3, 2019
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
Peiran Yang, Cai Read, Rhoda E Kuc, et al.
Stem Cells and Development
|
December 1, 2020
BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma
Amy L Strong, Philip J Spreadborough, Devaveena Dey, et al.
Biochemical Pharmacology
|
August 30, 2025
5-HT<sub>2a</sub>R contributes to pulmonary arterial hypertension by modulating the AHR pathway
Xiaoxuan Lu, Huiyuan Hu, Yuying Liu, et al.
Respiratory Research
|
July 12, 2025
Dysregulation of immune cells and platelet-monocyte aggregates in chronic thromboembolic pulmonary hypertension
Lu Sun, Haobo Li, Xincheng Li, et al.
Thrombosis Research
|
March 25, 2025
Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism
Haobing Zhang, Xiaoxuan Lu, Zhuangjie Guo, et al.
Signal Transduction and Targeted Therapy
|
May 13, 2022
Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration
Mingyao Wang, Zhe Zhang, Jiangfeng Liu, et al.
Circulation
|
February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
Peiran Yang, Cai Read, Rhoda E Kuc, et al.
Iscience
|
February 9, 2024
Serum proteome profiling reveals heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension
Yunxia Zhang, Meng Zhang, Hongwei Yang, et al.
Molecular & Cellular Proteomics : MCP
|
April 19, 2024
Proteome, Lysine Acetylome, and Succinylome Identify Posttranslational Modification of STAT1 as a Novel Drug Target in Silicosis
Tiantian Zhang, Yiyang Wang, Youliang Sun, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 90) with videos related to
Sort By:
Page
of 9
Journal of Human Genetics
|
August 3, 2023
Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development
Haobo Li, Zhu Zhang, Yuting Qiu, et al.
British Journal of Pharmacology
|
February 3, 2019
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
Peiran Yang, Cai Read, Rhoda E Kuc, et al.
Stem Cells and Development
|
December 1, 2020
BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma
Amy L Strong, Philip J Spreadborough, Devaveena Dey, et al.
Biochemical Pharmacology
|
August 30, 2025
5-HT<sub>2a</sub>R contributes to pulmonary arterial hypertension by modulating the AHR pathway
Xiaoxuan Lu, Huiyuan Hu, Yuying Liu, et al.
Respiratory Research
|
July 12, 2025
Dysregulation of immune cells and platelet-monocyte aggregates in chronic thromboembolic pulmonary hypertension
Lu Sun, Haobo Li, Xincheng Li, et al.
Thrombosis Research
|
March 25, 2025
Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism
Haobing Zhang, Xiaoxuan Lu, Zhuangjie Guo, et al.
Signal Transduction and Targeted Therapy
|
May 13, 2022
Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration
Mingyao Wang, Zhe Zhang, Jiangfeng Liu, et al.
Circulation
|
February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
Peiran Yang, Cai Read, Rhoda E Kuc, et al.
Iscience
|
February 9, 2024
Serum proteome profiling reveals heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension
Yunxia Zhang, Meng Zhang, Hongwei Yang, et al.
Molecular & Cellular Proteomics : MCP
|
April 19, 2024
Proteome, Lysine Acetylome, and Succinylome Identify Posttranslational Modification of STAT1 as a Novel Drug Target in Silicosis
Tiantian Zhang, Yiyang Wang, Youliang Sun, et al.
Page
of 9